Free Trial
LON:MXCT

MaxCyte (MXCT) Share Price, News & Analysis

MaxCyte logo
GBX 2.28 +0.03 (+1.33%)
As of 07/10/2025

About MaxCyte Stock (LON:MXCT)

Key Stats

Today's Range
2.21
2.31
50-Day Range
2.17
205
52-Week Range
147.69
407.84
Volume
665,121 shs
Average Volume
42,065 shs
Market Capitalization
£3.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MXCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter.

MXCT Stock News Headlines

Craig-Hallum Keeps Their Buy Rating on MaxCyte (MXCT)
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
6MXCT : A Look at MaxCyte's Upcoming...
MaxCyte to Propose AIM Delisting to Shareholders
See More Headlines

MXCT Stock Analysis - Frequently Asked Questions

MaxCyte's stock was trading at GBX 321.20 on January 1st, 2025. Since then, MXCT shares have decreased by 99.3% and is now trading at GBX 2.28.

Shares of MXCT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that MaxCyte investors own include HSBC (HSBA), Royal Dutch Shell (RDSB), Cassava Sciences (SAVA), EQTEC (EQT), Grafton Group (GFTU), Lloyds Banking Group (LLOY) and Marks and Spencer Group (MKS).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
Business Services
Current Symbol
LON:MXCT
CIK
N/A
Fax
N/A
Employees
80
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (27.29)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£45.08 million
Net Margins
-78.37%
Pretax Margin
N/A
Return on Equity
-16.01%
Return on Assets
-11.07%

Debt

Debt-to-Equity Ratio
8.59
Current Ratio
9.81
Quick Ratio
14.38

Sales & Book Value

Annual Sales
£57.52 million
Price / Sales
0.05
Cash Flow
GBX 1.16 per share
Price / Cash Flow
1.97
Book Value
GBX 203.85 per share
Price / Book
0.01

Miscellaneous

Outstanding Shares
132,004,040
Free Float
N/A
Market Cap
£3.01 million
Optionable
Not Optionable
Beta
1.13
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (LON:MXCT) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners